Skip to main content
Top
Published in: Inflammation Research 12/2015

01-12-2015 | Original Research Paper

OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis

Authors: Dongmei Zhang, Yongxia Cai, Minmin Chen, Lili Gao, Yanbo Shen, Zhongwei Huang

Published in: Inflammation Research | Issue 12/2015

Login to get access

Abstract

Objective

Activation of the transcription factor κB (NF-κB) and secretion of pro-inflammatory mediators are major events in acute pancreatitis (AP). Recently, O-linked-N-acetylglucosamine (O-GlcNAc) modification, one type of posttranslational modifications, reportedly attunes NF-κB function. However, the expression of O-GlcNAc transferase (OGT), the enzyme responsible for O-GlcNAcylation of proteins, in AP, and the possible contribution of OGT-mediated O-GlcNAcylation to the NF-κB inflammatory activation in pancreatic acinar cells and to the AP progression have not been understood. This study focused on the effects and mechanisms of OGT-mediated O-GlcNAcylation during AP.

Methods

An AP cell model was established with the caerulein-stimulated AR42 J rat pancreatic acinar cells. The secretion of pro-inflammatory cytokines TNF-α was detected by ELISA kits, and the production of NO was determined using the colorimetric Griess reaction. Expression of OGT was measured by RT-PCR and Western blot. Expression levels of RL2, phosphorylation of p65, total p65, IKKα were detected by Western blot. The NF-κB activity was evaluated by luciferase reporter gene assay. To determine the biological functions of OGT in caerulein-induced inflammatory response, RNA interference and PUGNAc, the inhibitor of O-GlcNAcase (OGA) was employed to regulate OGT expression in AR42 J cells.

Results

Caerulein significantly up-regulated the expression of OGT, and increased the global protein O-GlcNAcylation level in AR42 J cells. Reduction of OGT by small interfering RNA (siRNA) inhibited caerulein-triggered inflammation, assessed by the production of pro-inflammatory mediators (TNF-α and NO). We also demonstrated that O-GlcNAcylation directly modified the NF-κB p65 subunit and its upstream activating kinases IKKα in AR42 J cells. Lowering O-GlcNAcylation by OGT knockdown attenuated p65 activating phosphorylation, nuclear translocation, NF-κB transcriptional activity and levels of NF-κB transcriptional targets TNF-α and NO; on the contrary, elevating O-GlcNAc through PUGNAc increased IKKα and p65 O-GlcNAcylation accompanied by increased p65 phosphorylation, activity and levels of TNF-α and NO in caerulein-treated cells.

Conclusions

Our results demonstrate for the first time that OGT-mediated O-GlcNAcylation promotes NF-κB signaling activation and inflammation in pancreatic acinar cells, which might promote the progression of AP.
Literature
1.
go back to reference Huang H, Liu Y, Daniluk J, Gaiser S, Chu J, Wang H, et al. Activation of nuclear factor-kappaB in acinar cells increases the severity of pancreatitis in mice. Gastroenterology. 2013;144:202–10.PubMedCentralCrossRefPubMed Huang H, Liu Y, Daniluk J, Gaiser S, Chu J, Wang H, et al. Activation of nuclear factor-kappaB in acinar cells increases the severity of pancreatitis in mice. Gastroenterology. 2013;144:202–10.PubMedCentralCrossRefPubMed
2.
go back to reference Wan H, Yuan Y, Liu J, Chen G. Pioglitazone, a PPAR-gamma activator, attenuates the severity of cerulein-induced acute pancreatitis by modulating early growth response-1 transcription factor. Transl. Res. 2012;160:153–61.CrossRefPubMed Wan H, Yuan Y, Liu J, Chen G. Pioglitazone, a PPAR-gamma activator, attenuates the severity of cerulein-induced acute pancreatitis by modulating early growth response-1 transcription factor. Transl. Res. 2012;160:153–61.CrossRefPubMed
3.
go back to reference Rakonczay Z Jr, Hegyi P, Takacs T, McCarroll J, Saluja AK. The role of NF-kappaB activation in the pathogenesis of acute pancreatitis. Gut. 2008;57:259–67.CrossRefPubMed Rakonczay Z Jr, Hegyi P, Takacs T, McCarroll J, Saluja AK. The role of NF-kappaB activation in the pathogenesis of acute pancreatitis. Gut. 2008;57:259–67.CrossRefPubMed
4.
go back to reference Baumann B, Wagner M, Aleksic T, von Wichert G, Weber CK, Adler G, et al. Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo. J Clin Investig. 2007;117:1502–13.PubMedCentralCrossRefPubMed Baumann B, Wagner M, Aleksic T, von Wichert G, Weber CK, Adler G, et al. Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo. J Clin Investig. 2007;117:1502–13.PubMedCentralCrossRefPubMed
5.
go back to reference Algul H, Treiber M, Lesina M, Nakhai H, Saur D, Geisler F, et al. Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis. J Clin Investig. 2007;117:1490–501.PubMedCentralCrossRefPubMed Algul H, Treiber M, Lesina M, Nakhai H, Saur D, Geisler F, et al. Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis. J Clin Investig. 2007;117:1490–501.PubMedCentralCrossRefPubMed
7.
go back to reference Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, et al. Pathophysiology of acute pancreatitis. Pancreatology. 2005;5:132–44.CrossRefPubMed Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, et al. Pathophysiology of acute pancreatitis. Pancreatology. 2005;5:132–44.CrossRefPubMed
8.
go back to reference Lima VV, Spitler K, Choi H, Webb RC, Tostes RC. O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter? Clin Sci. 2012;123:473–86.PubMedCentralCrossRefPubMed Lima VV, Spitler K, Choi H, Webb RC, Tostes RC. O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter? Clin Sci. 2012;123:473–86.PubMedCentralCrossRefPubMed
9.
go back to reference Allison DF, Wamsley JJ, Kumar M, Li D, Gray LG, Hart GW, et al. Modification of RelA by O-linked-N-acetylglucosamine links glucose metabolism to NF-kappaB acetylation and transcription. Proc Natl Acad Sci USA. 2012;109:16888–93.PubMedCentralCrossRefPubMed Allison DF, Wamsley JJ, Kumar M, Li D, Gray LG, Hart GW, et al. Modification of RelA by O-linked-N-acetylglucosamine links glucose metabolism to NF-kappaB acetylation and transcription. Proc Natl Acad Sci USA. 2012;109:16888–93.PubMedCentralCrossRefPubMed
10.
go back to reference Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem. 2011;80:825–58.PubMedCentralCrossRefPubMed Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem. 2011;80:825–58.PubMedCentralCrossRefPubMed
11.
go back to reference Zachara NE, Hart GW. Cell signaling, the essential role of O-GlcNAc! Biochim Biophys Acta. 2006;1761:599–617.CrossRefPubMed Zachara NE, Hart GW. Cell signaling, the essential role of O-GlcNAc! Biochim Biophys Acta. 2006;1761:599–617.CrossRefPubMed
12.
go back to reference Li MD, Ruan HB, Singh JP, Zhao L, Zhao T, Azarhoush S, et al. O-GlcNAc transferase is involved in glucocorticoid receptor-mediated transrepression. J Biol Chem. 2012;287:12904–12.PubMedCentralCrossRefPubMed Li MD, Ruan HB, Singh JP, Zhao L, Zhao T, Azarhoush S, et al. O-GlcNAc transferase is involved in glucocorticoid receptor-mediated transrepression. J Biol Chem. 2012;287:12904–12.PubMedCentralCrossRefPubMed
13.
14.
go back to reference Lefebvre T, Dehennaut V, Guinez C, Olivier S, Drougat L, Mir AM, et al. Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer’s disease. Biochim Biophys Acta. 2010;1800:67–79.CrossRefPubMed Lefebvre T, Dehennaut V, Guinez C, Olivier S, Drougat L, Mir AM, et al. Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer’s disease. Biochim Biophys Acta. 2010;1800:67–79.CrossRefPubMed
15.
go back to reference Groves JA, Lee A, Yildirir G, Zachara NE. Dynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis. Cell Stress & Chaperones. 2013;18:535–58.CrossRef Groves JA, Lee A, Yildirir G, Zachara NE. Dynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis. Cell Stress & Chaperones. 2013;18:535–58.CrossRef
16.
go back to reference Itkonen HM, Minner S, Guldvik IJ, Sandmann MJ, Tsourlakis MC, Berge V, et al. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. Cancer Res. 2013;73:5277–87.CrossRefPubMed Itkonen HM, Minner S, Guldvik IJ, Sandmann MJ, Tsourlakis MC, Berge V, et al. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. Cancer Res. 2013;73:5277–87.CrossRefPubMed
17.
go back to reference Kanwal S, Fardini Y, Pagesy P, N’Tumba-Byn T, Pierre-Eugene C, Masson E, et al. O-GlcNAcylation-inducing treatments inhibit estrogen receptor alpha expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells. PLoS One. 2013;8:e69150.PubMedCentralCrossRefPubMed Kanwal S, Fardini Y, Pagesy P, N’Tumba-Byn T, Pierre-Eugene C, Masson E, et al. O-GlcNAcylation-inducing treatments inhibit estrogen receptor alpha expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells. PLoS One. 2013;8:e69150.PubMedCentralCrossRefPubMed
18.
go back to reference Golks A, Tran TT, Goetschy JF, Guerini D. Requirement for O-linked-N-acetylglucosaminyltransferase in lymphocytes activation. EMBO J. 2007;26:4368–79.PubMedCentralCrossRefPubMed Golks A, Tran TT, Goetschy JF, Guerini D. Requirement for O-linked-N-acetylglucosaminyltransferase in lymphocytes activation. EMBO J. 2007;26:4368–79.PubMedCentralCrossRefPubMed
19.
go back to reference Pathak S, Borodkin VS, Albarbarawi O, Campbell DG, Ibrahim A, van Aalten DM. O-GlcNAcylation of TAB 1 modulates TAK1-mediated cytokine release. EMBO J. 2012;31:1394–404.PubMedCentralCrossRefPubMed Pathak S, Borodkin VS, Albarbarawi O, Campbell DG, Ibrahim A, van Aalten DM. O-GlcNAcylation of TAB 1 modulates TAK1-mediated cytokine release. EMBO J. 2012;31:1394–404.PubMedCentralCrossRefPubMed
20.
go back to reference Goldberg H, Whiteside C, Fantus IG. O-linked beta-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells. Am. J. Physiol. Endocrinol. Metab. 2011;301:E713–26.CrossRefPubMed Goldberg H, Whiteside C, Fantus IG. O-linked beta-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells. Am. J. Physiol. Endocrinol. Metab. 2011;301:E713–26.CrossRefPubMed
21.
go back to reference Zhang D, Sun L, Zhu H, Wang L, Wu W, Xie J, et al. Microglial LOX-1 reacts with extracellular HSP60 to bridge neuroinflammation and neurotoxicity. Neurochem Int. 2012;61:1021–35.CrossRefPubMed Zhang D, Sun L, Zhu H, Wang L, Wu W, Xie J, et al. Microglial LOX-1 reacts with extracellular HSP60 to bridge neuroinflammation and neurotoxicity. Neurochem Int. 2012;61:1021–35.CrossRefPubMed
22.
go back to reference Ma Z, Vocadlo DJ, Vosseller K. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-kappaB activity in pancreatic cancer cells. J Biol Chem. 2013;288:15121–30.PubMedCentralCrossRefPubMed Ma Z, Vocadlo DJ, Vosseller K. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-kappaB activity in pancreatic cancer cells. J Biol Chem. 2013;288:15121–30.PubMedCentralCrossRefPubMed
23.
go back to reference Li Y, Liu H, Xu QS, Du YG, Xu J. Chitosan oligosaccharides block LPS-induced O-GlcNAcylation of NF-kappaB and endothelial inflammatory response. Carbohydr Polym. 2014;99:568–78.CrossRefPubMed Li Y, Liu H, Xu QS, Du YG, Xu J. Chitosan oligosaccharides block LPS-induced O-GlcNAcylation of NF-kappaB and endothelial inflammatory response. Carbohydr Polym. 2014;99:568–78.CrossRefPubMed
24.
go back to reference Yang WH, Park SY, Nam HW, Kim do H, Kang JG, Kang ES, et al. NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc Natl Acad Sci USA. 2008;105:17345–50.PubMedCentralCrossRefPubMed Yang WH, Park SY, Nam HW, Kim do H, Kang JG, Kang ES, et al. NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc Natl Acad Sci USA. 2008;105:17345–50.PubMedCentralCrossRefPubMed
25.
go back to reference James LR, Tang D, Ingram A, Ly H, Thai K, Cai L, et al. Flux through the hexosamine pathway is a determinant of nuclear factor kappaB-dependent promoter activation. Diabetes. 2002;51:1146–56.CrossRefPubMed James LR, Tang D, Ingram A, Ly H, Thai K, Cai L, et al. Flux through the hexosamine pathway is a determinant of nuclear factor kappaB-dependent promoter activation. Diabetes. 2002;51:1146–56.CrossRefPubMed
26.
go back to reference Robinson K, Vona-Davis L, Riggs D, Jackson B, McFadden D. Peptide YY attenuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42 J. J Am Coll Surg. 2006;202:788–96.CrossRefPubMed Robinson K, Vona-Davis L, Riggs D, Jackson B, McFadden D. Peptide YY attenuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42 J. J Am Coll Surg. 2006;202:788–96.CrossRefPubMed
27.
go back to reference Sonda S, Silva AB, Grabliauskaite K, Saponara E, Weber A, Jang JH, et al. Serotonin regulates amylase secretion and acinar cell damage during murine pancreatitis. Gut. 2013;62:890–8.CrossRefPubMed Sonda S, Silva AB, Grabliauskaite K, Saponara E, Weber A, Jang JH, et al. Serotonin regulates amylase secretion and acinar cell damage during murine pancreatitis. Gut. 2013;62:890–8.CrossRefPubMed
28.
go back to reference Zachara NE, O’Donnell N, Cheung WD, Mercer JJ, Marth JD, Hart GW. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem. 2004;279:30133–42.CrossRefPubMed Zachara NE, O’Donnell N, Cheung WD, Mercer JJ, Marth JD, Hart GW. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem. 2004;279:30133–42.CrossRefPubMed
29.
go back to reference Zachara NE, Hart GW. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta. 2004;1673:13–28.CrossRefPubMed Zachara NE, Hart GW. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta. 2004;1673:13–28.CrossRefPubMed
30.
go back to reference Chen CL, Liang CM, Chen YH, Tai MC, Lu DW, Chen JT. Glucosamine modulates TNF-alpha-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2012;53:2281–91.CrossRefPubMed Chen CL, Liang CM, Chen YH, Tai MC, Lu DW, Chen JT. Glucosamine modulates TNF-alpha-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2012;53:2281–91.CrossRefPubMed
31.
go back to reference Liu H, Wang Z, Yu S, Xu J. Proteasomal degradation of O-GlcNAc transferase elevates hypoxia-induced vascular endothelial inflammatory response dagger. Cardiovasc Res. 2014;103:131–9.PubMedCentralCrossRefPubMed Liu H, Wang Z, Yu S, Xu J. Proteasomal degradation of O-GlcNAc transferase elevates hypoxia-induced vascular endothelial inflammatory response dagger. Cardiovasc Res. 2014;103:131–9.PubMedCentralCrossRefPubMed
Metadata
Title
OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis
Authors
Dongmei Zhang
Yongxia Cai
Minmin Chen
Lili Gao
Yanbo Shen
Zhongwei Huang
Publication date
01-12-2015
Publisher
Springer Basel
Published in
Inflammation Research / Issue 12/2015
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-015-0877-y

Other articles of this Issue 12/2015

Inflammation Research 12/2015 Go to the issue